4//SEC Filing
HANSON GREGORY P 4
Accession 0001415889-18-000064
CIK 0001109196other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 6:00 AM ET
Size
14.0 KB
Accession
0001415889-18-000064
Insider Transaction Report
Form 4
HANSON GREGORY P
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-01-10$0.96/sh−66,550$63,888→ 411,815 total - Sale
Common Stock
2018-01-11$0.98/sh−38,697$37,923→ 373,118 total - Exercise/Conversion
Restricted Stock Unit
2018-01-08−449,159→ 0 total→ Common Stock (449,159 underlying) - Sale
Common Stock
2018-01-12$0.96/sh−11,232$10,783→ 361,886 total - Exercise/Conversion
Common Stock
2018-01-08+449,159→ 478,365 total
Footnotes (7)
- [F1]Represents conversion of restricted stock units into common stock upon vesting of such units granted on September 15, 2017 and October 2, 2017.
- [F2]Represents a portion of the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II of the reporting person. This sale is mandated by the Issuer's election under the equity incentive plan to require satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.87 to $1.02 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.95 to $1.02 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.95 to $1.00 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
- [F7]Restricted Stock Units vested on January 8, 2018, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date.
Documents
Issuer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK 0001109196
Entity typeother
Related Parties
1- filerCIK 0001186120
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 6:00 AM ET
- Size
- 14.0 KB